Search
Becton Dickinson and Co
BDXAdd to Watchlist
187.620USD
+0.020+0.01%
Close 08-20 16:00（ET）
51.11BMarket Cap
47.28P/E TTM
Forecast
Currency: USD Updated: 2026-08-19The current earnings forecast score of Becton Dickinson and Co is 7.25, ranking 142 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 201.92, with a high of 265.34 and a low of 183.00.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
197.847
Target Price
+9.45%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Becton Dickinson and Co
BDX
17
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
Zimmer Biomet Holdings Inc
ZBH
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Becton Dickinson and Co's expected revenue for the next quarter?
Becton Dickinson and Co's expected revenue is 5.11B.
What is Becton Dickinson and Co's price target?
Analysts forecast that Becton Dickinson and Co's price target is USD 201.92, with the highest forecast at USD 265.34 and the lowest forecast at USD 183.00.
How have Becton Dickinson and CoBDX's recent earnings per share performed?
The market expectation was USD 1.37, while Becton Dickinson and CoBDX's earnings per share (EPS) for the previous quarter was USD -1.11. EPS for the next quarter is expected at USD 4.07.
What is the analyst rating for Becton Dickinson and Co?
Based on the ratings of Becton Dickinson and Co's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.